Qube Research & Technologies (QRT)
LPCN icon

Qube Research & Technologies (QRT)’s Lipocine LPCN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,416
Closed -$26K – 2776
2021
Q3 		$26K Buy
+1,416
New +$31.2K ﹤0.01% 1942
2021
Q2 		– Sell
-1,387
Closed -$36K – 2577
2021
Q1 		$36K Sell
1,387
-5,762
-81% -$166K ﹤0.01% 1793
2020
Q4 		$165K Sell
7,149
-10,980
-61% -$264K ﹤0.01% 1564
2020
Q3 		$435K Buy
18,129
+14,877
+457% +$395K 0.01% 1095
2020
Q2 		$70K Buy
+3,252
New +$42.1K ﹤0.01% 1557

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LPCN Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Lipocine (LPCN) in Q4 2021, closing a stake of 1,416 shares — an estimated $26K sold.

Qube Research & Technologies (QRT) first reported a position in LPCN in Q2 2020 and held it in 5 quarters. The position peaked at $435K in Q3 2020. 39 funds tracked by Wall St. Rank hold LPCN as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Lipocine position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,416 Lipocine shares in Q4 2021, an estimated $26K.
  • Qube Research & Technologies (QRT) first reported a position in Lipocine in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Lipocine position peaked at $435K in Q3 2020.
  • 39 funds tracked by Wall St. Rank held Lipocine as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.